Contract Modifications
Modification | Description |
---|---|
Modifications 001 - 018 | Modifications 001 - 018 |
Modification 019 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 9 for FY 2021. |
Modification 020 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 9 for FY 2021. Funds in the amount of $8,693,712.02 are hereby obligated to CLIN 0001. |
Modification 021 | Obligate funds to CLIN 0001,Reimbursable Work Commercial (Non-Appropriated) in accordance with BSRA FINPLAN No. 9 for FY 2021. Funds in the amount of $237,652.91 are hereby obligated to CLIN 0001. |
Modification 022 | Incorporate Battelle Savannah River Alliance (BSRA) LLC, Fiscal Year 22 Performance Evaluation Measurement Plan (PEMP) for the period of October 1, 2021 through September 30, 2022. |
Modification 023 | Obligate funds to CLIN 0001,Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 10 for FY 2021. |
Modification 024 | Incorporate the Battelle Savannah River Alliance (BSRA) Advance Agreement (AA), Related to Impacts Resulting from the Emerging COVID Vaccine Policy associated with COVID-19 epidemic impacts at the Department of Energy Savannah River Operations Office (DOE-SR) Management and Operating Contract (M&O) for the Savannah River National Laboratory (SRNL). |
Modification 025 | Incorporate the attached FAR Deviation text in Section I of the contract as included in the Civilian Agency Acquisition Council (CAAC) Letter 2021-03, dated September 30, 2021. |
Modification 026 | Obligate funds to CLIN 0001, DOE FUNDS in accordance with BSRA FINPLAN No. 11 for FY 2022. Funds in the amount of $10,995,025.90 are hereby obligated to CLIN 0001. |
Modification 027 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 12 for FY 2022. |
Modification 028 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 12 for FY 2022. Funds in the amount of $3,013,415.48 are hereby obligated to CLIN 0001. |
Modification 029 | Obligate funds to CLIN 0001,Reimbursable Work Commercial (Non-Appropriated) in accordance with BSRA FINPLAN No. 12 for FY 2022. Funds in the amount of $221,178.64 are hereby obligated to CLIN 0001. |
Modification 030 | Obligate funds to CLIN 0001,Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 13 for FY 2022. Funds in the amount of $6,702,250.00 are hereby obligated to CLIN 0001. |
Modification 031 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 13 for FY 2022. Funds in the amount of $8,910,293.34 are hereby obligated to CLIN 0001. |
Modification 032 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) in accordance with Battelle Savannah River Alliance Financial Plan Number 13. Funds in the amount of $1,641,690.29 are hereby obligated to CLIN 0001. |
Modification 033 | Obligate funds to CLIN 0001, Reimbursable Work for other Agency in accordance with Battelle Savannah River Alliance Financial Plan Number 14. Funds in the amount of $3,765,229.20 are hereby obligated to CLIN 0001. |
Modification 034 | Obligate funds to CLIN 0001, DOE Funds in accordance with Battelle Savannah River Alliance Financial Plan Number 14. Funds in the amount of $8,920,840.00 are hereby obligated to CLIN 0001. |
Modification 035 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) in accordance with Battelle Savannah River Alliance Financial Plan Number 14. Funds in the amount of $430,000.00 are hereby obligated to CLIN 0001. |
Modification 036 | Incorporate eight (8) contract work authorizations. |
Modification 037 | Incorporate contract work authorization No. HQTD1005-21, Rev 0 for Radioactive Glass Waste Form Studies (see Attachment A). |
Modification 038 | Incorporate seven (7) contract work authorizations. |
Modification 039 | Obligate funds to CLIN 0001 Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 15 for FY 2022. Funds in the amount of $2,686,919.98 are hereby obligated to CLIN 0001. |
Modification 040 | Obligate funds to CLIN 0001 in accordance with BSRA FINPLAN No. 15 for FY 2022. Funds in the amount of $288,176.00 are hereby obligated to CLIN 0001. |
Modification 041 | Obligate funds to CLIN 0001 Reimbursable Work Commercial (Non-Appropriated) Funds in accordance with BSRA FINPLAN No. 15. Funds in the amount of $317,927.55 are hereby obligated to CLIN 0001. |
Modification 042 | Update attachment J-5.1 List B- Department of Energy Directives. |
Modification 043 | Incorporate six (6) contract work authorizations |
Modification 044 | Incorporate one (1) contract work authorizations |
Modification 045 | Incorporate fifteen (15) contract work authorizations |
Modification 046 | Incorporate five (5) contract work authorizations |
Modification 047 | Incorporate nine (9) contract work authorizations |
Modification 048 | Incorporate six (6) contract work authorizations |
Modification 049 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 16 for FY 2022. Funds in the amount of $762,867.19 are hereby obligated to CLIN 0001 |
Modification 050 | Obligate funds to CLIN 0001 DOE Funds in accordance with BSRA FINPLAN No. 16 for FY 2022. Funds in the amount of $4,407,320.62 are hereby obligated to CLIN 0001 |
Modification 051 | Obligate funds to CLIN 0001 Reimbursable Work Commercial (Non-Appropriated) in accordance with BSRA FINPLAN No. 16 for FY 2022. Funds in the amount of $74,793.20 are hereby obligated to CLIN 0001 |
Modification 052 | Incorporate seven (7) contract work authorizations. |
Modification 053 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 17 for FY 2022. Funds in the amount of $1,958,388.58 are hereby obligated to CLIN 0001 |
Modification 054 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 17 for FY 2022. Funds in the amount of $54,736,018.47 are hereby obligated to CLIN 0001 |
Modification 055 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) in accordance with BSRA FINPLAN No. 17 for FY 2022. Funds in the amount of $416,480.58 are hereby obligated to CLIN 0001 |
Modification 056 | Obligate funds to CLIN 0001,Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 18 for FY 2022. Funds in the amount of $1,877,676.78 are hereby obligated to CLIN 0001 |
Modification 057 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 18 for FY 2022. Funds in the amount of $20,437,263.66 are hereby obligated to CLIN 0001 |
Modification 058 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) in accordance with BSRA FINPLAN No. 18 for FY 2022. Funds in the amount of $303,966.68 are hereby obligated to CLIN 0001 |
Modification 059 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 19 for FY 2022. Funds in the amount of $11,227,989.41 are hereby obligated to CLIN 0001 |
Modification 060 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 19 for FY 2022. Funds in the amount of $1,781,826.91 are hereby obligated to CLIN 0001 |
Modification 061 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) in accordance with BSRA FINPLAN No. 19 for FY 2022. Funds in the amount of $19,485.06 are hereby obligated to CLIN 0001 |
Modification 062 | Incorporate eight (8) contract work authorizations |
Modification 063 | Updated Responsible Corporate Official (SEP 2017) contacts (Clause H.18 DOE-H-7020) |
Modification 064 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 20 for FY 2022. Funds in the amount of $634,915.98 are hereby obligated to CLIN 0001 |
Modification 065 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 20 for FY 2022. Funds in the amount of $3,717,483.56 are hereby obligated to CLIN 0001 |
Modification 066 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non- Appropriated) in accordance with BSRA FINPLAN No. 20 for FY 2022. Funds in the amount of $151,497.58 are hereby obligated to CLIN 0001 |
Modification 067 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 21 for FY 2022. Funds in the amount of $480,000.00 are hereby obligated to CLIN 0001 |
Modification 068 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 21 for FY 2022. Funds in the amount of $16,188,791.15 are hereby obligated to CLIN 0001 |
Modification 069 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) in accordance with BSRA FINPLAN No. 21 for FY 2022. Funds in the amount of $498,403.86 are hereby obligated to CLIN 0001 |
Modification 070 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 22 for FY 2022. Funds in the amount of $4,100,014.63 are hereby obligated to CLIN 0001 |
Modification 071 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 22 for FY 2022. Funds in the amount of $9,158,096.96 are hereby obligated to CLIN 0001 |
Modification 072 | Deobligate funds to CLIN 0001, Reimbursable Work Commercial (Non Appropriated in accordance with BSRA FINPLAN No. 22 for FY 2022. Funds in the amount of -$15,707.53 are hereby deobligated to CLIN 0001 |
Modification 073 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 23 for FY 2022. Funds in the amount of $15,000.00 are hereby obligated to CLIN 0001 |
Modification 074 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 23 for FY 2022. Funds in the amount of $1,800,000.00 are hereby obligated to CLIN 0001 |
Modification 075 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) in accordance with BSRA FINPLAN No. 23 for FY 2022. Funds in the amount of $93,122.43 are hereby obligated to CLIN 0001 |
Modification 076 | Incorporate Battelle Savannah River Alliance (BSRA) LLC. Fiscal Year 2023 Performance Evaluation Measurement Plan (PEMP) for the period of October 1, 2022 through September 30, 2023. |
Modification 077 | Update attachment J-5.1 List B - Department of Energy Directives in Section J of the contract |
Modification 078 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 24 for FY 2023. Funds in the amount of $968,932.04 are hereby obligated to CLIN 0001 |
Modification 079 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 24 for FY 2023. Funds in the amount of $13,424,929.32 are hereby obligated to CLIN 0001 |
Modification 080 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) in accordance with BSRA FINPLAN No. 24 for FY 2023. Funds in the amount of $193,375.29 are hereby obligated to CLIN 0001 |
Modification 081 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 25 for FY 2023. Funds in the amount of $399,980.58 are hereby obligated to CLIN 0001 |
Modification 082 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 25 for FY 2023. Funds in the amount of $7,327,737.76 are hereby obligated to CLIN 0001 |
Modification 083 | De-obligate funds from CLIN 0001, Reimbursable Commercial Work (Non- Appropriated) in accordance with BSRA FINPLAN No. 25 for FY 2023. Funds in the amount of -$52,510.61 are hereby de-obligated from CLIN 0001 |
Modification 084 | Incorporate thirteen (13) contract work authorizations |
Modification 085 | Incorporate twelve (12) contract work authorizations |
Modification 086 | Incorporate twelve (12) contract work authorizations |
Modification 087 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 26 for FY 2023. Funds in the amount of $8,081,346.59 are hereby obligated to CLIN 0001 |
Modification 088 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 26 for FY 2023. Funds in the amount of $2,603,414.00 are hereby obligated to CLIN 0001 |
Modification 089 | Obligate funds from CLIN 0001, Reimbursable Commercial Work (Non- Appropriated) in accordance with BSRA FINPLAN No. 26 for FY 2023. Funds in the amount of $657,877.81 are hereby obligated from CLIN 0001 |
Modification 090 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 27 for FY 2023. Funds in the amount of $4,802,831.77 are hereby obligated to CLIN 0001 |
Modification 091 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 27 for FY 2023. Funds in the amount of $7,723,253.00 are hereby obligated to CLIN 0001 |
Modification 092 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) in accordance with BSRA FINPLAN No. 27 for FY 2023. Funds in the amount of $390,664.93 are hereby obligated to CLIN 0001 |
Modification 093 | Update attachment J-5.1 List B - Department of Energy Directives in Section J of the contract |
Modification 094 | Incorporate by reference (IBR) FAR clause 52.216-7 Allowable Cost and Payment (AUG 2018), and Environmental Management Corporate Reachback Provisions into the contract |
Modification 095 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 28 for FY 2023. Funds in the amount of $2,654,744.16 are hereby obligated to CLIN 0001 |
Modification 096 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 28 for FY 2023. Funds in the amount of $88,975,737.88 are hereby obligated to CLIN 0001 |
Modification 097 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) Funds in accordance with BSRA FINPLAN No. 28 for FY 2023. Funds in the amount of $364,582.10 are hereby obligated to CLIN 0001 |
Modification 098 | Obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 30 for FY 2023. Funds in the amount of $1,049,765.00 are hereby obligated to CLIN 0001 |
Modification 099 | Obligate funds to CLIN 0001, DOE Funds in accordance with BSRA FINPLAN No. 30 for FY 2023. Funds in the amount of 14,642,459.00 are hereby obligated to CLIN 0001 |
Modification 100 | Obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) Funds in accordance with BSRA FINPLAN No. 30 for FY 2023. Funds in the amount of $114,514.67 are hereby obligated to CLIN 0001 |
Modification 101 | The purpose of this modification is to obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 31 for FY 2023. Funds in the amount of $2,501,612.16 |
Modification 102 | The purpose of this modification is to obligate funds to CLIN 0001, Department of Energy Funds in accordance with BSRA FINPLAN No. 31 for FY 2023. Funds in the amount of $41,498,362.91 |
Modification 103 | The purpose of this modification is to obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) Funds in accordance with BSRA FINPLAN No. 31 for FY 2023. Funds in the amount of $747,073.02 |
Modification 104 | The purpose of this modification is to obligate funds to CLIN 0001, Reimbursable Work for Other Federal Agency in accordance with BSRA FINPLAN No. 32 for FY 2023. Funds in the amount of $15,575,317.43 |
Modification 105 | The purpose of this modification is to obligate funds to CLIN 0001, Department of Energy Funds in accordance with BSRA FINPLAN No. 32 for FY 2023. Funds in the amount of $42,961,617.79 are hereby obligated to CLIN 0001 |
Modification 106 | The purpose of this modification is to obligate funds to CLIN 0001, Reimbursable Work Commercial (Non-Appropriated) Funds in accordance with BSRA FINPLAN No. 32 for FY 2023. Funds in the amount of $618,002.83 |
Modification 107 | The purpose of this modification is to remove Covid clauses and add FAR 52.204-27 |
Modification 108 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Appropriated) |
Modification 109 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Appropriated) |
Modification 110 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Non-Appropriated) |
Modification 111 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Appropriated) |
Modification 112 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Appropriated) |
Modification 113 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Non-Appropriated) |
Modification 114 | Incorporate the amount of Award Fee Incentive earned for the period October 1, 2021 to September 30, 2022 |
Modification 115 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Appropriated) |
Modification 116 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Appropriated) |
Modification 117 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Non-Appropriated) |
Modification 118 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Appropriated) |
Modification 119 | Obligate Funds to CLIN 0001 for DOE Funds (Appropriated) |
Modification 120 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Non-Appropriated) |
Modification 121 | Administrative Modification to change CO from Marie Garvin to Lennie K. Mattis |
Modification 122 | Incorporate FY 23 PEMP Rev. 1 for BSRA Contract |
Modification 123 | Incorporate FY 24 PEMP for BSRA Contract |
Modification 124 | Administrative Modification to change Funds previously erroneously cited as Non-Appropriated on 89303321CEM000080 Mod 117. |
Modification 125 | Obligate Funds to CLIN 0001-Reimbursable Work for Other Federal Agency (Appropriated) |
Modification 126 | Obligate Funds to CLIN 0001 for DOE Funds (Appropriated) |
Modification 127 | Obligate Funds to CLIN 0001 for DOE Funds (Appropriated) |
Modification 128 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Non-Appropriated) |
Modification 129 | Obligate Funds to CLIN 0001 for DOE Funds (Appropriated) |
Modification 130 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Non-Appropriated) |
Modification 131 | Updates to Attachment J-5.1 List B |
Modification 132 | Obligate Funds to CLIN 0001-Reimbursable Work for Other Federal Agency (Appropriated) |
Modification 133 | Obligate Funds to CLIN 0001-Reimbursable Work for Other Federal Agency (Appropriated) |
Modification 134 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Non-Appropriated) |
Modification 135 | Obligate Funds to CLIN 0001-Reimbursable Work for Other Federal Agency (Appropriated) |
Modification 136 | Obligate Funds to CLIN 0001 for DOE Funds (Appropriated) |
Modification 137 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Non-Appropriated) |
Modification 138 | Obligate Funds to CLIN 0001-Reimbursable Work for Other Federal Agency (Appropriated) |
Modification 139 | Obligate Funds to CLIN 0001 for DOE Funds (Appropriated) |
Modification 140 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Non-Appropriated) |
Modification 141 | Obligate Funds to CLIN 0001-Reimbursable Work for Other Federal Agency (Appropriated) |
Modification 142 | Obligate Funds to CLIN 0001 for DOE Funds (Appropriated) |
Modification 143 | Obligate Funds to CLIN 0001 for Reimbursable Work Commercial (Non-Appropriated) |
Modification 144 | The purpose of this modification is to inform the contractor of the amount of subjective performance fee to be awarded to BSRA for the period October 1, 2022 to September 30, 2023 |